CB2 Insights

CB2 Insights acquires medical cannabis clinic group in Colorado and Arizona

CB2 Insights (CBII) CEO Prad Sekar joined Steve Darling from proactive Investors on Skype to discuss CB2’s acquisition of MedEval Clinic LLC, a medical cannabis evaluation and education center group with multiple locations in Colorado and Arizona.

Sekar discussed why they decided to do the deal and how it fits in the overall strategy at CB2. Sekar also addressed the clinics model and revenue expected to be generated. 

Quick facts: CB2 Insights

Price: $0.14

Market: CSE
Market Cap: $11.03 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of CB2 Insights named herein, including the promotion by the Company of CB2 Insights in any Content on the Site, the Company receives from said...



Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

2 days, 7 hours ago

2 min read